Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
08 2019
Historique:
received: 24 05 2018
accepted: 10 01 2019
pubmed: 19 1 2019
medline: 17 6 2020
entrez: 19 1 2019
Statut: ppublish

Résumé

The prognostic implications of

Identifiants

pubmed: 30655366
pii: haematol.2018.197848
doi: 10.3324/haematol.2018.197848
pmc: PMC6669163
doi:

Substances chimiques

DNMT3A protein, human 0
DNA (Cytosine-5-)-Methyltransferases EC 2.1.1.37
DNA Methyltransferase 3A EC 2.1.1.37

Banques de données

ClinicalTrials.gov
['NCT00222027', 'NCT00327678']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1617-1625

Informations de copyright

Copyright© 2019 Ferrata Storti Foundation.

Références

Blood. 2003 Apr 1;101(7):2693-703
pubmed: 12446444
Blood. 2008 Jan 1;111(1):376-8
pubmed: 17901244
J Clin Oncol. 2009 Feb 20;27(6):911-8
pubmed: 19124805
Lancet Oncol. 2009 Feb;10(2):147-56
pubmed: 19147408
N Engl J Med. 2010 Dec 16;363(25):2424-33
pubmed: 21067377
Nat Genet. 2011 Mar 13;43(4):309-15
pubmed: 21399634
Pediatr Blood Cancer. 2011 Aug;57(2):204-9
pubmed: 21504050
Leukemia. 2011 Jul;25(7):1217-9
pubmed: 21537334
Blood. 2011 Oct 6;118(14):3932-41
pubmed: 21828135
Blood. 2011 Nov 17;118(20):5593-603
pubmed: 21881046
Br J Haematol. 2012 Feb;156(3):413-4
pubmed: 21981547
Leukemia. 2012 May;26(5):1106-7
pubmed: 22124213
J Exp Med. 2011 Dec 19;208(13):2571-9
pubmed: 22162831
N Engl J Med. 2012 Jan 5;366(1):95-6
pubmed: 22216861
Nature. 2012 Jan 11;481(7380):157-63
pubmed: 22237106
Leukemia. 2012 Jun;26(6):1247-54
pubmed: 22289988
J Clin Oncol. 2012 Mar 1;30(7):742-50
pubmed: 22291079
Blood. 2012 Jun 14;119(24):5824-31
pubmed: 22490330
Genes Chromosomes Cancer. 2013 Apr;52(4):410-22
pubmed: 23341344
Leukemia. 2013 Jul;27(7):1573-8
pubmed: 23519389
Blood. 2013 Jun 6;121(23):4749-52
pubmed: 23603912
Blood. 2013 Jul 4;122(1):74-82
pubmed: 23687089
J Clin Oncol. 2013 Dec 1;31(34):4333-42
pubmed: 24166518
Leukemia. 2014 Feb;28(2):241-7
pubmed: 24220272
Nat Genet. 2014 Feb;46(2):171-5
pubmed: 24413737
Nature. 2014 Feb 20;506(7488):328-33
pubmed: 24522528
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2548-53
pubmed: 24550281
Nat Commun. 2014 Apr 08;5:3630
pubmed: 24710217
PLoS One. 2014 Jun 17;9(6):e93353
pubmed: 24936645
Nat Med. 2014 Dec;20(12):1472-8
pubmed: 25326804
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
J Clin Oncol. 2015 Jun 20;33(18):2072-83
pubmed: 25964253
Nat Genet. 2015 Sep;47(9):1011-9
pubmed: 26192916
Haematologica. 2016 Jun;101(6):732-40
pubmed: 26944475
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
J Clin Oncol. 2017 Aug 10;35(23):2683-2691
pubmed: 28605290
Clin Epigenetics. 2018 Apr 2;10:42
pubmed: 29619119

Auteurs

Jonathan Bond (J)

Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.
Systems Biology Ireland, School of Medicine, University College Dublin, Ireland.
National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland.

Aurore Touzart (A)

Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.

Stéphane Leprêtre (S)

INSERM U1245 and Department of Hematology, Centre Henri Becquerel and Normandie Université UNIROUEN, Rouen, France.

Carlos Graux (C)

Department of Hematology, Université Catholique de Louvain (UCL), Centre Hospitalier Universitaire (CHU) Namur - Godinne site, Yvoir, Belgium.

Mario Bargetzi (M)

University Medical Department, Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Swiss Group for Clinical Cancer Research (SAKK), Bern, Switerland.

Ludovic Lhermitte (L)

Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.

Guillaume Hypolite (G)

Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.

Thibaut Leguay (T)

Department of Hematology, CHU de Bordeaux, France.

Yosr Hicheri (Y)

Hematology Service, Hôpital St Eloi, Montpellier, France.

Gaëlle Guillerm (G)

Hematology Service, CHU de Brest, Brest, France.

Karin Bilger (K)

Hematology Service, CHU Hautepierre, Strasbourg, France.

Véronique Lhéritier (V)

Group for Research on Adult Acute Lymphoblastic Leukemia, Coordination Office, Centre Hospitalier Lyon Sud, Lyon, France.

Mathilde Hunault (M)

PRES LUNAM, CHU Angers Service des Maladies du Sang and CRCINA INSERM, Angers, France.

Françoise Huguet (F)

Department of Hematology, CHU de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.

Yves Chalandon (Y)

University Medical Department, Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Department of Oncology, Hematology Division, University Hospital, Geneva, Switzerland.

Norbert Ifrah (N)

PRES LUNAM, CHU Angers Service des Maladies du Sang and CRCINA INSERM, Angers, France.

Elizabeth Macintyre (E)

Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.

Hervé Dombret (H)

Université Paris Diderot, Institut Universitaire d'Hématologie, EA-3518, AP-HP, University Hospital Saint-Louis, Paris, France.

Vahid Asnafi (V)

Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.

Nicolas Boissel (N)

Université Paris Diderot, Institut Universitaire d'Hématologie, EA-3518, AP-HP, University Hospital Saint-Louis, Paris, France nicolas.boissel@aphp.fr.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH